High incidence of graft failure in children receiving CD34+ augmented elutriated allografts for nonmalignant diseases

[1]  M. Andreani,et al.  The cure of thalassemia by bone marrow transplantation. , 2002, Blood reviews.

[2]  R. Soiffer,et al.  The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation. , 2001, Blood.

[3]  A. Nowak‐Wegrzyn,et al.  Fatal warm autoimmune hemolytic anemia resulting from IgM autoagglutinins in an infant with severe combined immunodeficiency. , 2001, Journal of pediatric hematology/oncology.

[4]  F. Preijers,et al.  Outcome of T cell-depleted transplantation after conditioning with an intensified regimen in patients aged 50 years or more is comparable with that in younger patients , 2000, Bone Marrow Transplantation.

[5]  F. Locatelli,et al.  Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation. , 2000, Blood.

[6]  M. Grever,et al.  CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies , 1998, Bone Marrow Transplantation.

[7]  C Anasetti,et al.  Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. , 1998, The New England journal of medicine.

[8]  S. Mackinnon,et al.  T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease. , 1998, Blood.

[9]  F. Preijers,et al.  Outcome of transplantation for standard‐risk leukaemia with grafts depleted of lymphocytes after conditioning with an intensified regimen , 1997, British journal of haematology.

[10]  J. Davis,et al.  CD34+ stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftment but cyclosporine A is still required to reduce GVHD and morbidity. , 1997, Transplantation proceedings.

[11]  E. Copelan,et al.  Bone marrow engraftment following unrelated donor transplantation utilizing busulfan and cyclophosphamide preparatory chemotherapy. , 1996, Bone marrow transplantation.

[12]  M. Andreani,et al.  Marrow transplantation for patients with thalassemia: results in class 3 patients. , 1996, Blood.

[13]  K. Schepers,et al.  The clinical use of elutriation and positive stem cell selection columns to engineer the lymphocyte and stem cell composition of the allograft. , 1994, Progress in clinical and biological research.

[14]  A. Nademanee,et al.  Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease. , 1993, The New England journal of medicine.

[15]  G. Lucarelli,et al.  Bone marrow transplantation in class 2 thalassemia patients. , 1993, Bone marrow transplantation.

[16]  G. Lucarelli,et al.  Bone marrow transplantation in class 1 thalassemia patients. , 1993, Bone marrow transplantation.

[17]  M. Pepe,et al.  Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies. , 1991, Transplantation.

[18]  J. Wagner,et al.  Separation of pluripotent haematopoietic stem cells from spleen colony-forming cells , 1990, Nature.

[19]  J. Wagner,et al.  Bone marrow graft engineering by counterflow centrifugal elutriation: results of a phase I-II clinical trial. , 1990, Blood.

[20]  J. Raemaekers,et al.  Allogeneic bone marrow transplantation for leukemia with marrow grafts depleted of lymphocytes by counterflow centrifugation. , 1990, Blood.

[21]  B. Shank,et al.  Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: I. Analysis of risk factors and results of secondary transplants , 1989 .

[22]  Brenda,et al.  Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: I. Analysis of risk factors and results of secondary transplants. , 1989, Blood.

[23]  H. Deeg,et al.  Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants. , 1988, Bone marrow transplantation.

[24]  J. Wagner,et al.  Separation of rat bone marrow cells by counterflow centrifugal elutriation: a model for studying the effects of lymphocyte depletion. , 1988, Experimental hematology.

[25]  A. Donnenberg,et al.  Implementation of a semiclosed large scale counterflow centrifugal elutriation system , 1987, Journal of clinical apheresis.

[26]  A. Donnenberg,et al.  Large scale separation of human bone marrow by counterflow centrifugation elutriation. , 1986, Journal of immunological methods.

[27]  C. Haanen,et al.  Depletion of donor lymphocytes by counterflow centrifugation successfully prevents acute graft-versus-host disease in matched allogeneic marrow transplantation. , 1986, Blood.

[28]  K. Wilms,et al.  Effect of anti-T-cell globulin on GVHD in leukemic patients treated with BMT. , 1981, Transplantation proceedings.

[29]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .